{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:51:28Z","timestamp":1792547488634,"version":"4.5.0"},"reference-count":157,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the most common liver cancer as well as the most prevalent cause of death in the adult patient population with cirrhosis. The occurrence of HCC is primarily caused by chronic liver inflammation that might occur because of a viral infection, non-alcoholic fatty liver disease (NAFLD), or various lifestyle-associated factors. The objective of this review was to summarize the current knowledge regarding the microenvironment of HCC, indicating how immune- and non-immune-cell stroma might affect the onset and progression of HCC. Therefore, in the following narrative review, we described the role of tumor-infiltrating neutrophils, bone-marrow-derived cells, tumor-associated mast cells, cancer-associated fibroblasts, tumor-associated macrophages, liver-sinusoidal endothelial cells, lymphocytes, and certain cytokines in liver inflammation and the further progression to HCC. A better understanding of the HCC microenvironment might be crucial to introducing novel treatment strategies or combined therapies that could lead to more effective clinical outcomes.<\/jats:p>","DOI":"10.3390\/ijms251910233","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T03:49:46Z","timestamp":1727149786000},"page":"10233","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma\u2014From Inflammation to Hepatocellular Carcinoma Progression"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-8987","authenticated-orcid":false,"given":"Jacek","family":"Baj","sequence":"first","affiliation":[{"name":"Department of Correct, Clinical and Imaging Anatomy, Chair of Fundamental Sciences, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6597-1559","authenticated-orcid":false,"given":"Magdalena","family":"Ko\u0142odziej","sequence":"additional","affiliation":[{"name":"Chair and Department of Forensic Medicine, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-2436","authenticated-orcid":false,"given":"Joanna","family":"Kobak","sequence":"additional","affiliation":[{"name":"Chair and Department of Forensic Medicine, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Januszewski","sequence":"additional","affiliation":[{"name":"Department of Correct, Clinical and Imaging Anatomy, Chair of Fundamental Sciences, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Syty","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, John Paul the II Catholic University of Lublin, Konstantyn\u00f3w 1G, 20-708 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-1471","authenticated-orcid":false,"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[{"name":"Clinica Medica \u201cA. Murri\u201d, Department of Biomedical Sciences & Human Oncology, University of Bari Medical School, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8714-7627","authenticated-orcid":false,"given":"Alicja","family":"Forma","sequence":"additional","affiliation":[{"name":"Chair and Department of Forensic Medicine, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"ref_1","unstructured":"(2024, February 08). Absolute Numbers, Incidence, Both Sexes, in 2022. Available online: https:\/\/gco.iarc.fr\/today\/en\/dataviz\/pie?mode=cancer&group_populations=1&cancers=39."},{"key":"ref_2","unstructured":"(2024, February 08). Absolute Numbers, Incidence, Both Sexes, in 2022. Available online: https:\/\/gco.iarc.fr\/today\/en\/dataviz\/pie?mode=population&group_populations=0&cancers=11."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global Epidemiology and Genetics of Hepatocellular Carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","article-title":"Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver","volume":"39","author":"Bertocchi","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.3748\/wjg.v19.i43.7500","article-title":"Role of innate immunity in the development of hepatocellular carcinoma","volume":"19","author":"Aravalli","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3748\/wjg.v25.i19.2279","article-title":"Mechanisms of hepatocellular carcinoma progression","volume":"25","author":"Ogunwobi","year":"2019","journal-title":"World J Gastroenterol."},{"key":"ref_8","unstructured":"(2024, February 08). Hepatocellular Carcinoma, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559177\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejrad.2018.01.025","article-title":"Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines","volume":"101","author":"Ayuso","year":"2018","journal-title":"Eur. J. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s12276-020-00527-1","article-title":"Hepatocellular carcinoma: Old friends and new tricks","volume":"52","author":"Kim","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.dld.2018.03.014","article-title":"When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review","volume":"50","author":"Russo","year":"2018","journal-title":"Dig Liver Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/TP.0000000000003174","article-title":"Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference","volume":"104","author":"Mehta","year":"2020","journal-title":"Transplantation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","article-title":"Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence","volume":"72","author":"Raoul","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","article-title":"Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma","volume":"28","author":"Zhu","year":"2022","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: Trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3350\/cmh.2020.0203","article-title":"Alcohol and hepatocarcinogenesis","volume":"26","author":"Taniai","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3748\/wjg.v26.i38.5759","article-title":"Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma","volume":"26","author":"Lau","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of Hepatocellular Carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chen, Y. (2019). Tian ZHBV-Induced Immune Imbalance in the Development of HCC. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02048"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JHC.S307962","article-title":"The Mechanisms of HBV-Induced Hepatocellular Carcinoma","volume":"8","author":"Jiang","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100231","DOI":"10.1016\/j.jhepr.2021.100231","article-title":"NAFLD and MAFLD as emerging causes of HCC: A populational study","volume":"3","author":"Myers","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: How is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.fct.2018.11.047","article-title":"Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods","volume":"124","author":"Rushing","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Pickova, D., Ostry, V., Toman, J., and Malir, F. (2021). Aflatoxins: History, Significant Milestones, Recent Data on Their Toxicity and Ways to Mitigation. Toxins, 13.","DOI":"10.3390\/toxins13060399"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jhep.2022.12.029","article-title":"External validation of the PAGE-B score for HCC risk prediction in people living with HIV\/HBV coinfection","volume":"78","author":"Surial","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/tmi.13532","article-title":"The impact of HIV on hepatocellular cancer survival in Nigeria","volume":"26","author":"Okeke","year":"2021","journal-title":"Trop. Med. Int. Health"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"SenGupta, S., Hein, L.E., and Parent, C.A. (2021). The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.734188"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/imr.13176","article-title":"N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology","volume":"314","author":"Antuamwine","year":"2023","journal-title":"Immunol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/cas.13627","article-title":"Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer","volume":"109","author":"Wang","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1479-5876-12-7","article-title":"The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma","volume":"12","author":"Wang","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/SLA.0000000000002058","article-title":"Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer","volume":"267","author":"Zhang","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.cmet.2023.09.004","article-title":"Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1","volume":"35","author":"Zhao","year":"2023","journal-title":"Cell Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1515611","DOI":"10.1080\/2162402X.2018.1515611","article-title":"Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma","volume":"8","author":"Wang","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lee, J.H., and Hong, Y.M. (2024). The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12074-3"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.21037\/tcr-20-3237","article-title":"Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: A systematic review and meta-analysis","volume":"10","author":"Lin","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/35018642","article-title":"Hepatocytes from non-hepatic adult stem cells","volume":"406","author":"Alison","year":"2000","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.20892\/j.issn.2095-3941.2019.0369","article-title":"The role of bone marrow-derived cells in the origin of liver cancer revealed by single-cell sequencing","volume":"17","author":"Chen","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/liv.12338","article-title":"The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma","volume":"34","author":"Bayo","year":"2014","journal-title":"Liver Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mt.2008.3","article-title":"A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs","volume":"16","author":"Chen","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4161\/cbt.7.2.5296","article-title":"The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo","volume":"7","author":"Lu","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/cr.2008.40","article-title":"Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model","volume":"18","author":"Qiao","year":"2008","journal-title":"Cell Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/j.1349-7006.2010.01738.x","article-title":"Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/SLA.0b013e3182368c4f","article-title":"Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma","volume":"254","author":"Niess","year":"2011","journal-title":"Ann. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.dld.2013.10.008","article-title":"Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice","volume":"46","author":"Barone","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.6002\/ect.2020.0495","article-title":"Therapeutic Role of Bone Marrow-Derived Mesenchymal Stem Cells in Controlling Prognosis of Hepatocellular Carcinoma in a Murine Model","volume":"20","author":"Mansour","year":"2022","journal-title":"Exp. Clin. Transplant."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bayo, J., Fiore, E., and Aquino, J.B. (2014). Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095171"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"80235","DOI":"10.18632\/oncotarget.10288","article-title":"IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressive-ness","volume":"8","author":"Bayo","year":"2016","journal-title":"Oncotarget."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4161\/cbt.21347","article-title":"The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/mt.2011.93","article-title":"Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery","volume":"19","author":"Knoop","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9302496","DOI":"10.1155\/2022\/9302496","article-title":"Extracellular Vesicle-Encapsulated MicroRNA-375 from Bone Marrow-Derived Mesenchymal Stem Cells Inhibits Hepatocellular Carcinoma Progression through Regulating HOXB3-Mediated Wnt\/\u03b2-Catenin Pathway","volume":"2022","author":"Yu","year":"2022","journal-title":"Anal. Cell Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Wei, J., Lu, Y., Wang, R., Xu, X., Liu, Q., He, S., Pan, H., Liu, X., Yuan, B., and Ding, Y. (2021). MicroRNA-375: Potential cancer suppressor and therapeutic drug. Biosci. Rep., 41.","DOI":"10.1042\/BSR20211494"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.3748\/wjg.v11.i41.6521","article-title":"Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues","volume":"11","author":"Peng","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.2147\/OTT.S105368","article-title":"Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery","volume":"9","author":"Ammendola","year":"2016","journal-title":"Onco Targets Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3748\/wjg.v9.i7.1469","article-title":"Mast cells and human hepatocellular carcinoma","volume":"9","author":"Grizzi","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ammendola, M., Sacco, R., Sammarco, G., Donato, G., Montemurro, S., Ruggieri, E., Patruno, R., Marech, I., Cariello, M., and Vacca, A. (2014). Correlation between serum tryptase, mast cells positive to tryptase and microvascular density in colo-rectal cancer patients: Possible biological-clinical significance. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099512"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"703163","DOI":"10.1155\/2013\/703163","article-title":"Mast Cells Positive to Tryptase and c-Kit Receptor Expressing Cells Correlates with Angiogenesis in Gastric Cancer Patients Surgically Treated","volume":"2013","author":"Ammendola","year":"2013","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e3220","DOI":"10.1097\/MD.0000000000003220","article-title":"Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma","volume":"95","author":"Tu","year":"2016","journal-title":"Medicine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1349-7006.2009.01182.x","article-title":"Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma","volume":"100","author":"Ju","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2007.15.6521","article-title":"High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma","volume":"26","author":"Zhu","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","author":"Hoshida","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_64","first-page":"e66743","article-title":"Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software","volume":"206","author":"Ali","year":"2024","journal-title":"J. Vis. Exp."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4614257","DOI":"10.1155\/2021\/4614257","article-title":"Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma","volume":"2021","author":"Zhang","year":"2021","journal-title":"J. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: Physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/liv.12262","article-title":"Endothelial transdifferentiation in hepatocellular carcinoma: Loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival","volume":"33","author":"Mogler","year":"2013","journal-title":"Liver Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.25844","article-title":"Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice","volume":"56","author":"Schildberg","year":"2012","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00018-023-04966-7","article-title":"Liver endothelial cells in NAFLD and transition to NASH and HCC","volume":"80","author":"Velliou","year":"2023","journal-title":"Cell Mol. Life Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/jcp.25244","article-title":"Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells","volume":"231","author":"Manzi","year":"2016","journal-title":"J. Cell Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10456-014-9431-8","article-title":"Galectin-1 induces vascular permeability through the neuropilin-1\/vascular endothelial growth factor receptor-1 complex","volume":"17","author":"Wu","year":"2014","journal-title":"Angiogenesis"},{"key":"ref_73","first-page":"74","article-title":"Expression of galectin-1 in malignant tumors","volume":"31","author":"Demydenko","year":"2009","journal-title":"Exp. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10555-012-9388-2","article-title":"Galectin-1 as a potent target for cancer therapy: Role in the tumor microenvironment","volume":"31","author":"Ito","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Yu, Z., Guo, J., Liu, Y., Wang, M., Liu, Z., Gao, Y., and Huang, L. (2022). Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma. J. Nanobiotechnol., 20.","DOI":"10.1186\/s12951-021-01205-8"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","article-title":"The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins","volume":"58","author":"Marrone","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: Behind the molecular mechanisms of statins","volume":"64","author":"Marrone","year":"2015","journal-title":"Gut"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Koletsa, T., Mitroulis, I., and Germanidis, G. (2022). Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy. Cancers, 14.","DOI":"10.3390\/cancers14010226"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"McAllister","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1073\/pnas.1113744109","article-title":"Origins of tumor-associated macrophages and neutrophils","volume":"109","author":"Etzrodt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Yuan, Y., Wu, D., Li, J., Huang, D., Zhao, Y., Gao, T., Zhuang, Z., Cui, Y., Zheng, D.Y., and Tang, Y. (2023). Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1217400"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: From mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/1873-3468.12771","article-title":"Cellular metabolism of tumor-associated macrophages\u2014Functional impact and consequences","volume":"591","author":"Rabold","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12964-022-00872-w","article-title":"M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma","volume":"21","author":"Lu","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hao, X., Zheng, Z., Liu, H., Zhang, Y., Kang, J., Kong, X., Rong, D., Sun, G., Sun, G., and Liu, L. (2022). Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol., 56.","DOI":"10.1016\/j.redox.2022.102463"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","article-title":"TREM2+macrophages suppress CD8+T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma","volume":"79","author":"Tan","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Zhou, L., Wang, M., Guo, H., Hou, J., Zhang, Y., Li, M., Wu, X., Chen, X., and Wang, L. (2022). Integrated Analysis Highlights the Immunosuppressive Role of TREM2+Macrophages in Hepatocellular Carcinoma. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.848367"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Baglieri, J., Brenner, D.A., and Kisseleva, T. (2019). The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071723"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jcmgh.2023.01.006","article-title":"Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma","volume":"15","author":"Ying","year":"2023","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","author":"Schrader","year":"2011","journal-title":"Hepatology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","article-title":"Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41419-021-03545-7","article-title":"Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2\/miR-4756\/IFIT1\/3 axis","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.celrep.2016.04.019","article-title":"Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met\/FRA1\/HEY1 Signaling","volume":"15","author":"Lau","year":"2016","journal-title":"Cell Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1158\/0008-5472.CAN-20-4226","article-title":"FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness","volume":"81","author":"Loh","year":"2021","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cac2.12414","article-title":"Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib","volume":"43","author":"Eun","year":"2023","journal-title":"Cancer Commun."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Wang, X., Yuan, Z., Li, Z., He, X., Zhang, Y., Wang, X., Su, J., Wu, X., Li, M., and Du, F. (2024). Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: Basic principles and recent advances. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1354313"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.18632\/aging.202710","article-title":"The density of tumor-infiltrating lymphocytes and prognosis in resectable hepatocellular carcinoma: A two-phase study","volume":"13","author":"Gao","year":"2021","journal-title":"Aging"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Stulpinas, R., Zilenaite-Petrulaitiene, D., Rasmusson, A., Gulla, A., Grigonyte, A., Strupas, K., and Laurinavicius, A. (2023). Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples. Cancers, 15.","DOI":"10.3390\/cancers15020366"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12957-023-03009-6","article-title":"Prognostic values of tissue-resident CD8+T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"21","author":"Chen","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1038\/s41467-023-43462-1","article-title":"Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+exhausted-like T cells","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Bai, Y., Chen, D., Cheng, C., Li, Z., Chi, H., Zhang, Y., Zhang, X., Tang, S., Zhao, Q., and Ang, B. (2022). Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.950536"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"110986","DOI":"10.1016\/j.celrep.2022.110986","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory Tcells","volume":"39","author":"Gu","year":"2022","journal-title":"Cell Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Delgado, M.E., C\u00e1rdenas, B.I., Farran, N., and Fernandez, M. (2021). Metabolic reprogramming of liver fibrosis. Cells, 10.","DOI":"10.3390\/cells10123604"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.livres.2023.07.002","article-title":"Retinoic acid signaling in fatty liver disease","volume":"7","author":"Zhang","year":"2023","journal-title":"Liver Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Pei, Q., Yi, Q., and Tang, L. (2023). Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119671"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Chang, M.L., and Yang, S.S. (2019). Metabolic signature of hepatic fibrosis: From individual pathways to systems biology. Cells, 8.","DOI":"10.3390\/cells8111423"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41419-023-06077-4","article-title":"Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice","volume":"14","author":"Otto","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Ali, E., Trailin, A., Ambrozkiewicz, F., Li\u0161ka, V., and Hemminki, K. (2022). Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315292"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2020.12.015","article-title":"Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production","volume":"160","author":"Myojin","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","article-title":"Friend or foe? The elusive role of hepatic stellate cells in liver cancer","volume":"20","author":"Cogliati","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Quiroz Reyes, A.G., Lozano Sepulveda, S.A., Martinez-Acu\u00f1a, N., Islas, J.F., Gonzalez, P.D., Heredia Torres, T.G., Perez, J.R., and Garza Trevi\u00f1o, E.N. (2023). Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma. Technol. Cancer Res. Treat., 22.","DOI":"10.1177\/15330338231163677"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhang, T., Sun, M., Ji, X., Xie, M., Huang, W., and XIA, L. (2021). Therapeutic values of myeloid-derived suppressor cells in hepatocellular carcinoma: Facts and hopes. Cancers, 13.","DOI":"10.3390\/cancers13205127"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/JHC.S159693","article-title":"Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: Current state and future perspectives","volume":"6","author":"Lu","year":"2019","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Weston, C.J., Zimmermann, H.W., and Adams, D.H. (2019). The role of myeloid-derived cells in the progression of liver disease. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00893"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Li, T., Zhang, X., Lv, Z., Gao, L., and Yan, H. (2020). Increased Expression of Myeloid-Derived Suppressor Cells in Patients with HBV-Related Hepatocellular Carcinoma. Biomed. Res. Int., 2020.","DOI":"10.1155\/2020\/6527192"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Zhang, X., Fu, X., Li, T., and Yan, H. (2019). The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225327"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/hep.30630","article-title":"A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Mitroulis, I., and Germanidis, G. (2021). Tumor-associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy. Cancers, 13.","DOI":"10.3390\/cancers13122899"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1042\/EBC20220245","article-title":"Harnessing neutrophil plasticity for HCC immunotherapy","volume":"67","author":"Geh","year":"2023","journal-title":"Essays Biochem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"216903","DOI":"10.1016\/j.canlet.2024.216903","article-title":"Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils","volume":"592","author":"Pan","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.imbio.2013.06.003","article-title":"Tumor associated macrophages and neutrophils in cancer","volume":"218","author":"Galdiero","year":"2013","journal-title":"Immunobiology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1479-5876-10-230","article-title":"After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma","volume":"10","author":"Kong","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"29333","DOI":"10.18632\/oncotarget.8787","article-title":"Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"key":"ref_132","unstructured":"Crusio, W.E., Lambris, J.D., and Radeke, H.H. (2024, February 08). Advances in Experimental Medicine and Biology. Volume 1234 Series Editors [Internet]. Available online: http:\/\/www.springer.com\/series\/5584."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Leone, P., Malerba, E., Susca, N., Favoino, E., Perosa, F., Brunori, G., Prete, M., and Racanelli, V. (2024). Endothelial cells in tumor microenvironment: Insights and perspectives. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1367875"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Yao, X., and Zeng, Y. (2023). Tumour associated endothelial cells: Origin, characteristics and role in metastasis and anti-angiogenic resistance. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1199225"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Kaps, L., and Schuppan, D. (2020). Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers. Cells, 9.","DOI":"10.3390\/cells9092027"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Jeng, K.S., Sheen, I.S., Lin, S.S., Leu, C.M., and Chang, C.F. (2021). The role of endoglin in hepatocellular carcinoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063208"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2301166","DOI":"10.1002\/advs.202301166","article-title":"FGF9 Recruits \u03b2-Catenin to Increase Hepatic ECMSynthesis Promote NASH-Driven HCC","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"101170","DOI":"10.1016\/j.xcrm.2023.101170","article-title":"The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability","volume":"4","author":"Roy","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref_139","first-page":"141","article-title":"Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease","volume":"31","author":"Okabe","year":"2016","journal-title":"Histol Histopathol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0039-1685539","article-title":"Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis","volume":"39","author":"Filliol","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ajpath.2022.02.004","article-title":"The Functional Roles of Immune Cells in Primary Liver Cancer","volume":"192","author":"Pham","year":"2022","journal-title":"Am. J. Pathol."},{"key":"ref_142","first-page":"718","article-title":"Prognostic role of immune cells in hepatocellular carcinoma","volume":"19","author":"Sachdeva","year":"2020","journal-title":"EXCLI J."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Fasano, R., Shadbad, M.A., Brunetti, O., Argentiero, A., Calabrese, A., Nardulli, P., Calbi, R., Baradaran, B., and Silvestris, N. (2021). Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy. Life, 11.","DOI":"10.3390\/life11121355"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1758835920922034","DOI":"10.1177\/1758835920922034","article-title":"Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model","volume":"12","author":"Teng","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Chen, C., Wang, Z., Ding, Y., and Qin, Y. (2023). Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1133308"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Wang, C.I., Chu, P.M., Chen, Y.L., Lin, Y.H., and Chen, C.Y. (2021). Chemotherapeutic drug-regulated cytokines might influence therapeutic efficacy in hcc. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413627"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Lin, Y.D., Wu, G.S., Rao, M.Y., Liu, Y.H., Han, Y.W., Zhang, J., and Zhang, J.W. (2024). Effect of cytokines on advanced hepatocellular carcinoma prognosis receiving radiotherapy and tislelizumab plus anlotinib: A single-center phase II clinical trial. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-62523-z"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Dewidar, B., Meyer, C., Dooley, S., and Meindl-Beinker, N. (2019). Tgf-\u03b2 in hepatic stellate cell activation and liver fibrogenesis\u2014Updated 2019. Cells, 8.","DOI":"10.3390\/cells8111419"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Pras, E., Fern\u00e1ndez-Iglesias, A., Gracia-Sancho, J., and P\u00e9rez-Del-pulgar, S. (2022). Cell death in hepatocellular carcinoma: Pathogenesis and therapeutic opportunities. Cancers, 14.","DOI":"10.3390\/cancers14010048"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Pocino, K., Stefanile, A., Basile, V., Napodano, C., D\u2019Ambrosio, F., Di Santo, R., Call\u00e0, C.A.M., Gulli, F., Saporito, R., and Ciasca, G. (2023). Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace. J. Pers. Med., 13.","DOI":"10.3390\/jpm13010005"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Alqahtani, A., Khan, Z., Alloghbi, A., Ahmed, T.S.S., Ashraf, M., and Hammouda, D.M. (2019). Hepatocellular carcinoma: Molecular mechanisms and targeted therapies. Medicina, 55.","DOI":"10.3390\/medicina55090526"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2018.07.001","article-title":"Tumor necrosis factor-\u03b1 promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells","volume":"434","author":"Jing","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Kumar, V., Kaur, J., Anand Pawar, V., Wang, Y., and Zhang, Y. (2022). IL-32 and IL-34 in hepatocellular carcinoma. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1051113"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Sakamoto, Y., Yoshio, S., Doi, H., Mori, T., Matsuda, M., Kawai, H., Shimagaki, T., Yoshikawa, S., Aoki, Y., and Osawa, Y. (2021). Increased Frequency of Dysfunctional Siglec-7\u2212CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.603133"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e1919","DOI":"10.1002\/onco.13899","article-title":"Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial","volume":"26","author":"Gao","year":"2021","journal-title":"Oncologist"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/carcin\/bgaa106","article-title":"Chemokines in hepatocellular carcinoma: A meta-analysis","volume":"41","author":"Pan","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3934\/mbe.2020070","article-title":"The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2020","journal-title":"Math. Biosci. Eng."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/19\/10233\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:01:04Z","timestamp":1760112064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/19\/10233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":157,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ijms251910233"],"URL":"https:\/\/doi.org\/10.3390\/ijms251910233","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]}}}